THERAPY is thought to be an invitation to foster and revive expert discussion among transfusion specialists, especially within Central Europe and adjacent regions. In this context, transfusion experts of Poland, Czech Republic, Slovakia, Hungary and Slovenia as the five 'Central European representatives' of the ten new EU members, of Bulgaria, Croatia, Romania, Serbia and Montenegro as 'EU candidate representatives' and of Switzerland, Austria and South Tyrol (northern part of Italy) as the 'old Central Europeans' were invited to report on national specifics, especially focusing on up-to-date topics such as quality, guidelines, laws and future challenges [1] [2] [3] [4] [5] [6] [7] [8] . German authors [9, 10] contributed overviews about the current EU Blood directive and accreditation needs for medical laboratories in Europe, whereas the author of 'Blood Transfusion in Europe: The White Book 2005' [11] gives his view on blood transfusion development within the next 10 years [12] . Taking a glimpse on the articles submitted, certain specific topics were addressed by several authors: cost containment, European self-sufficiency based on a respectful attitude to donors, and the need for compliance with (European) guidelines and laws using quality control as a tool to achieve these demands. Beside lifetime teaching, there is also a need to implement an European scale reflection i) in order 'to put the right person into the right job' and ii) for a better adjustment between training, qualification and professional practice [12] . With respect to first point mentioned above, recent developments in molecular biology, quality control topics, data management, and cost containment led to the employment of a new group of academic experts contributing to the success of modern blood banking. To look at the second point, the classical qualifications of medical doctors, medical technicians, nurses, and administrators experienced a supplementation by molecular biologists, pharmacists, computer scientists, statisticians, and economists. Within the next decade, their responsibilities and competencies need to be defined more clearly in order to recognize their co-operation and grant their teamwork. One should reflect, for instance, in detail on the question whether molecular biologists with a well defined level of experience should be granted a legally defined competency to validate molecular diagnoses within their own responsibility. Beside everyday routine and the implementation of legal issues and guidelines, blood banking as well as every other technology, needs constant improvement and further development. Most of the contributions to this issue come to mention the importance of innovative research for the future development of transfusion medicine. But how and why is research justified? How does research determine its aims? What is its reasonable context? To answer these questions, the understanding of an explicatory model originally developed by economists might help: According to Hinterhuber et al. [13] , 'core competency' is the only sustainable attribute delivering customer value. Core competency is in place, if the product is i) of benefit for the customer, ii) rarely encountered, iii) difficult to imitate and iv) not to substitute ( fig. 2) . Current research is only thought as a servant to achieve and support these four attributes, thereby granting core competency. Therefore, it might well make sense to think about the corecompetencies of modern blood banking and to focus on these Gassner talents for the future, rather than to disperse into to many disciplines. To exemplify, some of our 'block busters' -these customer-beneficial, rarely encountered, imitation-resistant and unreplaceable products -might be defined as 'cell therapeutics' (erythrocytes, platelets, etc.), others as the interrelated discipline-specific knowledge e.g. about the erythrocyte surface (blood groups). However defined, core competencies are obviously important and their sustaining research needs to be managed with diligence. Since financial resources are limited and the future challenges for innovations are numerous, the formation of cooperative networks is of great importance for active contributors in this field. Therefore, thinking in international benchmarks (rather than regional or national) will become an important topic. Primarily however, the previous excursion into the theories of research was mainly meant as a reflection about the conditions for the evolution and innovation of our current products and services since one important fact has to be kept in mind: it is the management, e.g. quality-control, guideline issuing and law enacting, which finally serve our products and services and not vice versa. First there is the product, then management.
1,000 km 1,000 miles Core-competency is in place, if the product is i) of benefit for the customer, ii) rarely encountered, iii) difficult to imitate and iv) not to substitute. The presence or absence of respective attributes leads to gradually improving market relevance.
